Kevin P. Rosenblatt
Papers
1
Total Citations
3
H-Index
1
About
Dr. Kevin P. Rosenblatt is a pioneer in the field of proteomic molecular profiling, with a focus on developing innovative technologies for cancer diagnostics and biomarker discovery. His major contributions center on advancing lysate array technology, particularly reverse-phase protein microarrays, which enable the simultaneous measurement of dozens to hundreds of proteins from minute patient biopsy samples. This work has profound implications for personalized medicine, allowing for detailed molecular characterization from limited clinical specimens. His 2011 paper on "Construction and Hyperspectral Imaging of Quantum Dot Lysate Arrays" introduced a novel approach using quantum dots for multiplexed protein detection, enhancing the sensitivity and throughput of proteomic analysis. While his citation counts reflect a specialized, emerging field, his foundational contributions have helped shape the trajectory of proteomic profiling, bridging the gap between complex protein mixtures and actionable clinical insights. Dr. Rosenblatt’s research continues to drive the evolution of molecular profiling technologies, offering new avenues for early disease detection and targeted therapeutic strategies.
Research Focus
Key Achievements
Top Papers
- 1Construction and Hyperspectral Imaging of Quantum Dot Lysate Arrays3 citations · 2011